Lad Inhibitors

Lad inhibitors are chemical entities that can diminish the functional activity of Lad, a protein involved in the regulation of cell shape via interaction with the actin cytoskeleton and myosin II. These inhibitors cover categories like myosin II inhibitors (Blebbistatin, ML-7, Y-27632), actin polymerization inhibitors (Latrunculin A, Cytochalasin D, Jasplakinolide, Phalloidin, SMIFH2, CK-666), and Rac GTPase inhibitors (EHT 1864, NSC 23766, Wiskostatin). By inhibiting these specific cellular processes and signaling molecules, the inhibitors can influence Lad's function without directly blocking its activity.

Blebbistatin, ML-7, and Y-27632inhibit myosin II or its regulators, leading to a disruption in actomyosin assembly and an impact on Lad-dependent cell shape regulation. On the other hand, Latrunculin A, Cytochalasin D, Jasplakinolide, Phalloidin, SMIFH2, and CK-666 target actin polymerization or depolymerization, thereby affecting the actin cytoskeleton dynamics and subsequently the Lad-mediated cellular processes. For instance, Latrunculin A and Cytochalasin D inhibit actin polymerization and filament elongation, respectively, while Jasplakinolide and Phalloidin stabilize actin filaments to inhibit their depolymerization. SMIFH2 and CK-666, in contrast, inhibit specific regulators of actin polymerization, namely formin and the Arp2/3 complex, respectively.